These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 26001553)

  • 1. U.S. Compounding Pharmacy-Related Outbreaks, 2001-2013: Public Health and Patient Safety Lessons Learned.
    Shehab N; Brown MN; Kallen AJ; Perz JF
    J Patient Saf; 2018 Sep; 14(3):164-173. PubMed ID: 26001553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Description of outbreaks of health-care-associated infections related to compounding pharmacies, 2000-12.
    Staes C; Jacobs J; Mayer J; Allen J
    Am J Health Syst Pharm; 2013 Aug; 70(15):1301-12. PubMed ID: 23867487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated endotoxin testing program for high-risk-level compounded sterile preparations at an institutional compounding pharmacy.
    Cooper JF; Latta KS; Smith D
    Am J Health Syst Pharm; 2010 Feb; 67(4):280-6. PubMed ID: 20133532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. End-preparation assessments and tests for compounded sterile preparations.
    McElhiney LF
    Int J Pharm Compd; 2013; 17(4):307-11. PubMed ID: 24261146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sterile compounding: clinical, legal, and regulatory implications for patient safety.
    Qureshi N; Wesolowicz L; Stievater T; Lin AT
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1183-91. PubMed ID: 25443512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Centralized insourcing of sterile compounding: One multihospital health system's journey.
    Bracero D; Carlos Pagan L; Rowe A; Cassano AT
    Am J Health Syst Pharm; 2022 Jul; 79(15):1281-1289. PubMed ID: 35443036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Instruction on compounded sterile preparations at U.S. schools of pharmacy.
    Hellums M; Alverson SP; Monk-Tutor MR
    Am J Health Syst Pharm; 2007 Nov; 64(21):2267-74. PubMed ID: 17959579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outbreak of Serratia marcescens bloodstream infections in patients receiving parenteral nutrition prepared by a compounding pharmacy.
    Gupta N; Hocevar SN; Moulton-Meissner HA; Stevens KM; McIntyre MG; Jensen B; Kuhar DT; Noble-Wang JA; Schnatz RG; Becker SC; Kastango ES; Shehab N; Kallen AJ
    Clin Infect Dis; 2014 Jul; 59(1):1-8. PubMed ID: 24729502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential risks of pharmacy compounding.
    Gudeman J; Jozwiakowski M; Chollet J; Randell M
    Drugs R D; 2013 Mar; 13(1):1-8. PubMed ID: 23526368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A collaborative effort to comply with USP chapter 797 for compounding sterile preparations for investigational use.
    Formea CM; Weiss WT; McCluskey SV
    Am J Health Syst Pharm; 2008 Jul; 65(13):1266-9. PubMed ID: 18574018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacy compounding of high-risk level products and patient safety.
    Mullarkey T
    Am J Health Syst Pharm; 2009 Sep; 66(17 Suppl 5):S4-13. PubMed ID: 19710449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multistate outbreak of Serratia marcescens bloodstream infection associated with contaminated intravenous magnesium sulfate from a compounding pharmacy.
    Sunenshine RH; Tan ET; Terashita DM; Jensen BJ; Kacica MA; Sickbert-Bennett EE; Noble-Wang JA; Palmieri MJ; Bopp DJ; Jernigan DB; Kazakova S; Bresnitz EA; Tan CG; McDonald LC
    Clin Infect Dis; 2007 Sep; 45(5):527-33. PubMed ID: 17682984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How gaps in regulation of compounding pharmacy set the stage for a multistate fungal meningitis outbreak.
    Teshome BF; Reveles KR; Lee GC; Ryan L; Frei CR
    J Am Pharm Assoc (2003); 2014; 54(4):441-5. PubMed ID: 25063265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compounding pharmacy conundrum: "we cannot live without them but we cannot live with them" according to the present paradigm.
    Guharoy R; Noviasky J; Haydar Z; Fakih MG; Hartman C
    Chest; 2013 Apr; 143(4):896-900. PubMed ID: 23412546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
    Kastango ES
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical Compounding: a History, Regulatory Overview, and Systematic Review of Compounding Errors.
    Watson CJ; Whitledge JD; Siani AM; Burns MM
    J Med Toxicol; 2021 Apr; 17(2):197-217. PubMed ID: 33140232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outbreak of bacteremia due to Burkholderia contaminans linked to intravenous fentanyl from an institutional compounding pharmacy.
    Moehring RW; Lewis SS; Isaacs PJ; Schell WA; Thomann WR; Althaus MM; Hazen KC; Dicks KV; Lipuma JJ; Chen LF; Sexton DJ
    JAMA Intern Med; 2014 Apr; 174(4):606-12. PubMed ID: 24493147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. History of sterile compounding in U.S. hospitals: learning from the tragic lessons of the past.
    Myers CE
    Am J Health Syst Pharm; 2013 Aug; 70(16):1414-27. PubMed ID: 23903480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigations of Possible Multistate Outbreaks of Salmonella, Shiga Toxin-Producing Escherichia coli, and Listeria monocytogenes Infections - United States, 2016.
    Marshall KE; Nguyen TA; Ablan M; Nichols MC; Robyn MP; Sundararaman P; Whitlock L; Wise ME; Jhung MA
    MMWR Surveill Summ; 2020 Nov; 69(6):1-14. PubMed ID: 33180756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Workforce planning and safe workload in sterile compounding hospital pharmacy services.
    Chaker A; Omair I; Mohamed WH; Mahomed SH; Siddiqui MA
    Am J Health Syst Pharm; 2022 Jan; 79(3):187-192. PubMed ID: 34605883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.